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Lack of association between
iron status at birth and growth
of preterm infants
Ausência de associação entre
indicadores de anemia ao
nascimento e crescimento de
prematuros
ABSTRACT
OBJECTIVE: To assess the association between iron status at birth and growth of
preterm infants.
METHODS: Ninety-five premature babies (26 to 36 weeks of gestational age) born
from July 2000 to May 2001 in a public hospital in Rio de Janeiro, Southeastern
Brazil, were followed up for six months, corrected by gestational age. Iron
measurements at birth were available for 82 mothers and 78 children: hemoglobin,
hematocrit, mean corpuscular volume and plasma iron. All children received free
doses of iron supplement (2 mg/kg/day) during the follow-up period and up to two
years of age. Multivariate linear regression analyses with repeated measurements
were performed to assess factors associated to linear growth.
RESULTS: Growth was more pronounced up to 40 weeks of gestational age,
increasing about 1.0 cm/week and then slowing down to 0.75 cm/week. The multivariate
analysis showed growth was positively associated with birth weight (0.4 cm/100 g;
p≤0.001) and negatively associated with gestational age at birth (-0.5 cm/week;
p≤0.001). There was no association between cord iron and mother iron measurements
and growth (p>0.60 for all measures). Only two children had anemia at birth, whereas
43.9% of mothers were anemic (hemoglobin <11 g/dl). Also, there was no correlation
between anemia indicators of mothers and children at birth (r<0.15; p>0.20).
CONCLUSIONS: Maternal anemia was not associated with anemia in preterm
infants and iron status of mothers and children at birth was not associated with short-
term growth of preterm infants.
KEYWORDS: Anemia. Infant, premature, growth & development. Iron,
blood.
RESUMO
OBJETIVO: Avaliar a associação entre indicadores de anemia no nascimento e o
crescimento de prematuros.
MÉTODOS: Crianças prematuras (26-36 semanas de idade gestacional) (n=95),
nascidas de julho de 2000 a maio de 2001, em hospital público do Rio de Janeiro,
foram seguidas por seis meses, corrigidos pela idade gestacional. Foram obtidos em
82 mães e 78 crianças os indicadores de anemia: hemoglobina, hematócrito, volume
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corpuscular médio e ferro plasmático. Os prematuros receberam suplemento de ferro
(2 mg/kg/dia) durante o seguimento. Análises de regressão linear multivariadas, com
medidas repetidas, avaliaram os fatores associados ao crescimento linear.
RESULTADOS: O crescimento dos prematuros foi mais acentuado até as 40 semanas
de idade gestacional, com aumento de aproximadamente 1,0cm/semana. Após essa
fase, o crescimento foi de 0,75 cm/semana. Na análise multivariada o crescimento
associou-se positivamente com o peso ao nascer (0,4 cm/100 g de peso ao nascer;
p≤0,001) e negativamente com a idade gestacional (-0,5 cm/semana; p≤0,001). Não se
observou associação entre os indicadores de anemia, tanto da mãe quanto das crianças
(p>0,60 para todos indicadores) e o crescimento. Somente duas crianças apresentavam
anemia no nascimento, enquanto 43,9% das mães apresentavam anemia
(hemoglobina<11 g/dl). Os indicadores de anemia da mãe e da criança no nascimento
também não apresentaram correlação importante (r<0,15; p>0,20).
CONCLUSÕES: A anemia materna não se associou com a anemia dos prematuros
no nascimento e os indicadores de anemia das mães e das crianças não influenciaram
o crescimento das crianças nascidas prematuras.
DESCRITORES: Anemia. Prematuro, crescimento e desenvolvimento. Ferro,
sangue.
INTRODUCTION
Anemia is a highly prevalent disease in Brazil.15 Al-
though enriching cereal products with iron became
mandatory in 2002, pregnant women from low socio-
economic groups still lack iron supplements on a
regular basis. A reduced dietary iron intake is the most
likely explanation for the high prevalence of iron
deficiency in both pregnant women and infants and
may contribute to slow catching up of children born
with low birth weight (LBW).19 Despite the abundant
literature on maternal anemia and birth weight, show-
ing that iron and folate deficiencies during pregnancy
contribute to increased incidence of preterm births
and fetal growth retardation,13 there are limited data
on the consequences of iron status on infant growth.
During early postnatal period a positive association
between infant anemia or iron deficiency with lack
of appetite and higher risk of infection has been
shown,9 therefore iron status at birth may explain the
catching up of preterm infants. Also, disease burden
among those LBW infants depends on their growth
pattern.12 In a population-based cohort study con-
ducted in Southern Brazil comprising 3,582 children
examined at birth, 20 and 42 months of age, catch-up
growth from zero to 20 months was related to subse-
quent risks of hospital admissions and mortality, and
those children who were small-for-gestational-age but
presented substantial weight gain (≥0.66 z-score) up
to the age of 20 months had 65% fewer subsequent
hospital admissions than the other small-for-gesta-
tional-age babies.23 These rapid-growing children had
admission and mortality rates similar to those ob-
served for children born with adequate birth weight
for their gestational age. These findings suggest that
growth promotion efforts for preterm babies may have
at least short-term benefits.
Despite the fact that anemia is the most worldwide
prevalent nutritional disease, the majority of studies
investigating the relationship between maternal and
child iron deficiency have focused on birth weight as
the endpoint and not growth of preterm children, a
high risk group for anemia. Thus, it was tested the hy-
pothesis that mother’s and children’s iron status at birth,
measured by hemoglobin, hematocrit and plasma iron,
would be associated with these children’s growth.
METHODS
A total of 215 preterm infants born from July 2000 to
May 2001 were admitted to a neonatal unit of a spe-
cialized preterm inpatient service in the municipal-
ity of Rio de Janeiro, Southeastern Brazil. Forty-seven
infants were excluded for congenital abnormalities
and/or chromosomal disorders. Forty-eight had no
blood collected due to small placenta, infants’ ill-
ness, mothers’ serious morbidity, blood coagulation
or because blood sample from umbilical cord could
not be collected. From the remaining 120 newborns,
three died in the first month, and 22 were never traced
for follow-up. Of the 95 premature babies (26 to 36
weeks of gestational age) followed up for six months
of corrected age, for some their blood samples pre-
sented hemolysis and only a sub-sample of 34 had
plasma iron measured in their blood cord. Among
children followed up at least one iron measurement
was available for 78 of them: 71 for hematocrit, 65
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for hemoglobin, 34 for plasma iron, and 65 for both
hematocrit and hemoglobin. For maternal iron status
measurements there were 82 samples and plasma iron
was measured in 34 of them.
A sample size of 50 infants with a type I error of 0.05
and a type II error of 0.20 allows to measure changes
greater than 4 cm in length.
Maternal venous blood samples were collected in
heparin tubes. Umbilical cords were clamped at birth
and blood samples were collected into heparinized
tubes by nurses previously trained. Whole blood sam-
ples were used for the testing of hemoglobin,
hematocrit and mean corpuscular volume in an auto-
mated system. All blood samples were centrifuged
within two hours of sampling and plasma samples
were stored at -70°C before being tested. Plasma sam-
ples (300 ml) were mixed with 1,050 µl of 0.5% nitric
acid and 150 µl internal standard (10 ppm scandium in
100 ppm Triton) for iron measurement by inductively
coupled plasma-atomic emission spectrometry using
Plasma 1000 Emission Spectrometer (Perkin-Elmer).
Gestational age was assessed by mothers’ report of
their last menstrual period (87 newborns), early ultra-
sound dating (two newborns) and New Ballard Score
examination (six newborns).2 Anthropometric meas-
urements of the infants were taken two hours after
delivery by nurses previously trained. Measures dur-
ing follow-up were taken by two research assistants
previously trained. Weight was measured using a 5 g
precision electronic scale. Length was obtained us-
ing a portable stadiometer, 1 mm precision. Demo-
graphic and socioeconomic data were collected be-
fore discharge.
Mothers who volunteered to participate in the study
were invited to attend visits on a monthly basis or at
any time their children were sick. At the scheduled
appointments anthropometric measures were taken
and mothers were counseled on feeding practices. The
study maternity hospital promotes breastfeeding and
nurses and medical staff are trained to support moth-
er’s decision to breastfeed. In the analysis, breastfeed-
ing duration was categorized into months regardless
of their frequency.
All children received free doses of iron supplement
(2 mg/kg/day) during the follow-up period and up to
two years of age.
Sex differences in the baseline anthropometric data
and hemoglobin were tested by Student’s t-test. Pos-
sible confounding variables in the association be-
tween hemoglobin at baseline and anthropometric
changes, such as mothers’ height, socioeconomic fac-
tors, newborn morbidity, and breastfeeding practice
were analyzed using ANOVA, Student’s t-test, or χ2.
Factors associated with growth were modeled using a
hierarchical framework. Criterion for inclusion in the
model was p<0.20 in the univariate analysis. Family
income and mother schooling were entered first. The
second level variables included mothers’ height, new-
borns’ gestational age, sex, birth weight, morbidity
(need for assisted ventilation and sepsis). The third
level included days of hospitalization during the first
six months and breastfeeding.
The effect of iron measurements at birth on growth was
analyzed based on temporal changes of infant’s length
examined through repeated-measures random regres-
sion analysis using SAS software program, version 8.0,
and PROC MIXED. The term of interest was the asso-
ciation between iron measures and the rate of change
in length, evaluated by iron-time interaction. Since
children attended visits in the outpatient clinic on an
irregular basis, with different numbers of follow-up
waves for each child, analysis was carried out by means
of linear random regression models with random inter-
cept and slope. For inclusion of the covariates models
were compared by Akaike’s information criterion. Af-
ter inclusion of confounding variables in the model its
Table 1 - Mean and standard deviation (SD) of cord hemoglobin, hematocrit and plasma iron in preterm infants according to
socioeconomic baseline factors and breastfeeding duration evaluated during follow-up. Rio de Janeiro, Brazil, 2000-2001.
Variable Hemoglobin (g/dl) Hematocrit (%) Plasma iron (µmol/l)
N Mean* SD N Mean* SD N Mean* SD
Family income
0.8-1.9 11 14.11 3.40 12 40.8 10.7 19 43.7 4.4
2.0-2.9 16 13.24 3.06 17 38.7 10.2 19 44.9 4.8
≥3.0 20 14.6 2.31 13 43.8 6.9 36 43.8 4.1
Schooling
<4 years 39 13.98 3.16 44 41.3 10.1 55 44.9 3.9
4-8 years 8 14.41 1.50 8 42.8 4.3 12 43.2 4.3
>8 years 18 15.10 2.15 19 43.9 6.4 28 43.3 5.0
Breastfeeding (days)
15-90 15 15.11 2.08 18 44.5 7.1 20 43.8 4.6
91-180 11 13.76 4.04 12 40.3 12.2 13 44.3 2.4
>180 21 14.64 2.11 22 42.4 7.6 33 45.6 3.9
*ANOVA p-value >0.20 for all measures
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covariance structure was tested by the likelihood ratio
test. The final model included only random intercept,
which is similar to an exchangeable covariance struc-
ture (compound symmetry).
The variable age was centered at 40 weeks (expected
duration of gestation) and was treated as a continuous
variable. Models accounted for a discontinuity in time
by the inclusion of two variables: time 1=minimum (ges-
tational age, 40 weeks) and time 2=maximum (0, age in
weeks +40) as suggested by Bryson5 (2003). These two
variables estimates change from birth up to 40 weeks of
gestational age and after 40 weeks. Upon examination
of residual plots of the models, length was square root
transformed, which was effective in linearizing the rela-
tionship and stabilizing the variance.16
Family income and mother’s schooling were catego-
rized as in Table 1. Only eight children developed
late-onset sepsis. Models were remained unchanged
with the inclusion of the variable morbidity.
The study was approved by the Research Ethics Com-
mittee of Instituto Fernandes Figueira (Fiocruz) and
mothers signed an informed consent.
RESULTS
Male and female babies showed no differences in
anthropometric measures or cord iron markers. How-
ever, females had a statistically significant lower ges-
tational age (Table 2). Mothers’ hematocrit and
hemoglobin measures were much lower than those
observed among infants (Table 2), but there was no
correlation between hemoglobin (r=0.04; p=0.74),
hematocrit (r=0.15; p=0.24) or plasma iron (r=0.21;
p=0.27) measures of mothers and infants. Only one
female baby and one male baby had anemia at birth
(cord blood hemoglobin level <10.5 g/dl), whereas
among mothers anemia was highly prevalent, as well
as inadequate plasma iron (<10.7 µmol/l), which was
seen in 32% of them (Table 2).
Factors that could affect child growth were explored
for their association with iron status. Cord
hemoglobin, hematocrit, and plasma iron were not
associated with family income, mother’s level of edu-
cation and breastfeeding duration throughout the
follow-up (Table 1). Mother’s height was also assessed
but only four mothers were below 1.50 m.
At birth it was found no association between mark-
ers of iron status and gestational age, weight, and
length. The effect of mother’s and infant’s iron status
at birth on infant’s growth was tested for hemoglobin,
hematocrit and plasma iron as continuous variables
and also by classifying mothers as anemic and non-
anemic according to the classification shown in Ta-
ble 2. Both crude and adjusted analyses showed no
effect of iron status on children growth. Data for the
multivariate analysis with cord hemoglobin is shown
in Table 3.
Results based on hematocrit were quite similar to
those for hemoglobin. For that reason data is shown
only for hemoglobin and plasma iron.
An overall comparison of iron effect on length mean,
adjusted for birth weight, gestational age and sex,
are shown for the models: 1) with the overall cohort
(N=95); 2) adjusted for mother hemoglobin (N=82);
and 3) adjusted for cord iron (N=43) (Figure). Only
estimated measures for anemic mothers and iron cord
below median are shown because lines cannot be
distinguished.
DISCUSSION
There is strong evidence that severe iron deficiency
causes growth impairment,18 but it remains unclear to
what extent iron status is related to growth. Prema-
ture infants are at risk for early postnatal iron defi-
ciency because they accrue less iron during gesta-
tion, grow more rapidly after birth, and are typically
undertreated with enteral iron.17 Regardless of that,
Table 2 - Anthropometric and iron status measurements of preterm infants and their mothers at birth. Rio de Janeiro, Brazil,
2000-2001.
Variable Male babies Female babies Mother
N Mean 95% CI N Mean 95% CI N Mean 95% CI
Gestational age (weeks)* 39 33.7 31.5-35.8 56 32.6 29.8-35.4
Birth weight (g) 39 2,087 1,457-2,717 56 1,924 1,223-2,625
Length (cm) 39 44.7 40.5-48.8 56 43.5 38.9-48.0
Hematocrit (%) 31 42.3 33.7-50.9 40 41.9 33.0-50.8 82 34.2 33.1-35.2
Hemoglobin (g/dl) 27 14.3 11.5-17.0 38 14.3 11.6-17.1 82 11.2 10.8-11.5
Plasma iron (µmol/l) 16 33.0 24.9-41.0 18 33.0 26.3-39.7 34 15.7 12.9-18.5
MCV (µm3) 80 87.6 82.2-92.8
Prevalence of anemia (%) %
Hemoglobin <11 g/dl 82 43.9 34.6-53.1
Hemoglobin <9.5 g/dl 82 9.8 4.5-15.1
MCV <84 µm3 80 22.0 13.9-30.0
*t-test with p-value <0.05 comparing sexes
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in the population of premature infants, some catch-
up to normal growth patterns is expected, making them
an interesting group to explore the association be-
tween iron status and growth. On the other hand, at
least in developing countries, preterm infants may
suffer from infectious diseases that could impair their
development and they may not receive adequate nu-
tritional care to ensure healthy growth. Therefore, it
was chosen a neonatal unit with strong support for
breastfeeding, caring mainly for low-income mothers
and with an approach for anemia prevention on in-
fancy that includes iron supplementation for all
preterm infants. Thus, the effect of both mother’s and
their premature infant’s iron status on health and
growth patterns, in relation to other factors that affect
growth, such as socioeconomic factors, was studied.
A limitation of the study was not to include a meas-
ure of compliance to iron supplementation.
The study sample was homogeneous with
respect to feeding practices and socioeco-
nomic parameters, as shown in Table 1. Also,
an effort was made to follow up the entire
cohort up to their sixth month of life, but
only 75% were followed up to the fifth month
and only 50% up to the end of the study
period. In addition, the repeated measurement
analysis used proved to be an effective way
of dealing with missing observations. Also,
after comparing baseline values of the losses
to follow-up with those followed up for six
months of corrected age there was no differ-
ence on gestational age, birth weight,
hemoglobin, family income, and mother
schooling. Any residual difference due to
incomplete follow-up would be towards the
association between iron status and growth,
because anemic children would come more
frequently to the care service. It was also
found no association at baseline between
birth weight, length and iron status. In a sys-
tematic review, Allen1 (2001) also found no
evidence to support a relationship between
iron deficiency as cause of premature birth and low
birth weight. Recent studies on iron supplementa-
tion showed that the effect is affected by the initial
maternal iron status, which allows placenta and fetus
to compete for iron.6
The study data also showed a non-significant tendency
to a negative correlation of blood cord hematocrit,
hemoglobin, and iron with birth weight. A possible
explanation for these negative associations at base-
line can be that fetal oxygen saturation is only 45%
and it is associated with high erythropoietin levels
and rapid red blood production.21 It is only during the
last two months of pregnancy that hemoglobin F, more
saturated with O
2
, is replaced with the adult
hemoglobin A. The most important factors regulating
hemoglobin-oxygen affinity are changes related to the
concentrations of red blood cell 2,3-diphosphogly-
Table 3 - Longitudinal linear regression analysis of cord blood hemoglobin, and covariates on length of preterm infants during
six-month follow-up for corrected age. Rio de Janeiro, Brazil, 2000-2001.
Regression coefficient Standard error p-value
Sex (Female/male) -0.34 0.61 0.57
Gestational age (weeks) -0.56 0.18 0.002
Birth weight (100 g) 0.34 0.062 <0.0001
Age weeks till 40 weeks - AGE1* 1.08 0.31 0.0008
Age after 40 weeks - AGE2* 0.63 0.06 <0.0001
Hemoglobin (HB) (g/dl) -0.128 0.825 0.74
HB - AGE1* 0.0016 0.021 0.93
HB - AGE2* -0.0027 0.0042 0.52
*Interaction between age in weeks until 40 weeks AGE1 (expected term date) and after 40 weeks -AGE2. If hemoglobin
had an effect on growth a statistically significant association would be expected. AGE1 and AGE2 allowed a discontinuity
in time. AGE1 = minimum (gestational age, 40 weeks) and AGE2 = maximum (0, age in weeks +40) as suggested by Singer
& Willett20 (2003)
Figure - Estimated means of length (cm) during six-month follow-up of
the overall cohort of preterm children (N=95), those preterm children
from anemic mothers (hemoglobin <11 mg/dl) (N=82) and those with
cord hemoglobin below the median (N=65; median=14.7 mg/dl). Rio de
Janeiro, Brazil, 2000-2001.
All cohort   (N total =95)      9             51          92           75          71         64           54         47
Mother Hb (N total =82)      7             43          75           64          60         49           46          34
Cord Hb     (Ntotal =65)      5             34           62           51         49          43           33         30
 Gestational age Postnatal age
cm
30
35
40
45
50
55
60
65
70
anemic
all cohort
iron<median
32 40 4 8 12 16 20   24
weeks
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cerate (2,3-DPG).21 The decline in fetal hemoglobin in
the newborn period appears to be strictly regulated.
The switchover from fetal hemoglobin to adult
hemoglobin synthesis follows a sigmoid curve with a
crossover point about 30 to 32 weeks post-concep-
tion. Consistent with these findings, the present study
found higher levels of hemoglobin and hematocrit in
children compared to mothers.
Several studies,10,11,14 but not all,3,4,22 have shown a
positive association between cord and maternal iron
status. In general, these associations are present when
mothers with severe anemia are included in the analy-
ses or when newborns from mothers with severe
anemia are compared with those of non-anemic moth-
ers. Otherwise when maternal moderate anemia is
present no associations are found.4,24 The data from
the present study showed no association of hematocrit,
hemoglobin and plasma iron measures between moth-
ers and infants. These results are consistent with the
absence of severe anemia in the mothers studied and
with a previous study of Brazilian mothers and in-
fants in early postpartum (1-5 days), which showed
no association between mothers and infants regard-
ing these variables, and also in ferritin values.22 Ma-
ternal iron status at the end of pregnancy or in early
postpartum may also affect infant status. De Benaze8
et al (1989) also found a positive association between
ferritin levels of mothers and those of two-month-old
children. Among children born to anemic mothers,
the odds ratio for anemia at two months age was 5.7
compared to children born from non-anemic moth-
ers; even after controlling for food intake, morbidity,
and socioeconomic level.7
Lack of power due to a small sample size is not a
probable explanation for the lack of association be-
tween iron status and growth, since a difference in
length of 4 cm, taken for sample size calculation,
have been reported in other studies.18
To the authors’ knowledge few studies have explored
the association between iron status at the time of birth
for preterm infants and their subsequent growth to the
gestational age of 40 weeks. This aspect of fetal/infant
growth appears to be an important step in the analysis
in order to adjust for the rapid growth of more prema-
ture children. Based on the results of this study, it is
concluded that maternal anemia is not associated with
anemia in preterm infants and that iron status of preterm
infants and their mothers, at the time of birth, is not
associated with short-term growth of preterm infants.
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